ASHP therapeutic position statement on optimizing treatment of hypertension

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2000年 / 57卷 / 02期
关键词：
American Society of Health-System Pharmacists; angiotensin converting enzyme inhibitors; calcium antagonists; diuretics; hypertension; protocols; sympatholytics agents;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：162 / 173
页数：12
相关论文
共 50 条
  • [21] ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (18) : 1839 - 1888
  • [22] Hypertension in the metabolic syndrome Summary of the new position statement of the European Society of Hypertension
    Redon, Josep
    Cifkova, Renata
    Narkiewicz, Krzysztof
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2009, 119 (04): : 255 - 259
  • [23] ASHP statement on the pharmacist's role in informatics
    Siska, Mark H.
    Barone, Louis D.
    Besier, James L.
    Clark, Toby
    Marvin, Kevin C.
    McCreadie, Scott R.
    Mitchell, Sandra H.
    Poikonen, John C.
    Schlesselman, Michael D.
    Shane, Rita R.
    Stevenson, James G.
    Taylor, Perry D.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (02) : 200 - 203
  • [24] 2021 Spanish Society of Hypertension position statement about telemedicine
    Gijon-Conde, T.
    Rubio, E.
    Gorostidi, M.
    Vinyoles, E.
    Armario, P.
    Rodilla, E.
    Segura, J.
    Divison-Garrote, J. A.
    Garcia-Donaire, J. A.
    Molinero, A.
    Ruilope, L. M.
    HIPERTENSION Y RIESGO VASCULAR, 2021, 38 (04): : 186 - 196
  • [25] ASHP statement on confidentiality of patient health care information
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (16) : 1664 - 1664
  • [26] ASHP statement on the pharmacist's role in primary care
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (16) : 1665 - 1667
  • [27] Spanish Society of Hypertension position statement on the 2017 ACC/AHAhypertension guidelines
    Gijon-Conde, T.
    Gorostidi, M.
    Camafort, M.
    Abad-Cardiel, M.
    Martin-Rioboo, E.
    Morales-Olivas, F.
    Vinyoles, E.
    Armario, P.
    Banegas, J. R.
    Coca, A.
    de la Sierra, A.
    Martell-Claros, N.
    Redon, J.
    Ruilope, L. M.
    Segura, J.
    HIPERTENSION Y RIESGO VASCULAR, 2018, 35 (03): : 119 - 129
  • [28] ASHP statement on pharmacist decision-making on assisted suicide
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (16) : 1661 - 1664
  • [29] Treatment of hypertension in diabetes: what is the best therapeutic option?
    Aksnes, Tonje A.
    Skarn, Sigrid N.
    Kjeldsen, Sverre E.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (06) : 727 - 734
  • [30] ASHP STATEMENT ON THE ROLE OF THE PHARMACIST IN PATIENT-FOCUSED CARE
    VOGEL, DP
    IVEY, MF
    STANLEY, R
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (16) : 1808 - 1810
12345